+987.9%
MRNA vs LSCC
+57.8%
+930.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LSCC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.3% | +11.9% | +13.0% |
| 7D | +20.6% | +3.0% | +17.7% | +20.3% |
| 30D | +27.1% | -19.3% | +46.4% | +27.5% |
| 3M | +353.4% | -22.3% | +375.7% | +367.9% |
| 6M | +446.3% | -14.6% | +460.8% | +431.2% |
| YTD | +776.2% | +45.8% | +730.4% | +539.4% |
| 1Y | +987.9% | +69.6% | +918.3% | +625.4% |
| All | +987.9% | +57.8% | +930.1% | +625.4% |
Cumulative growth
Daily Returns
Daily percentage return beside LSCC.
Daily Out/Under-Performance
Portfolio return minus LSCC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LSCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LSCC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling